Trial Profile
A cross-sectional study of sitagliptin versus oral antihyperglycemic agents in elderly patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2018
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 01 Feb 2018 Results assessing differences in baseline characteristics and comorbidities of elderly patients with type 2 diabetes published in the Diabetes Therapy
- 19 Oct 2016 New trial record
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes